Hollow Brook Wealth Management Decreased Holding in Gilead Sciences (GILD) as Stock Price Declined; Orthofix Intl N V (OFIX) Stake Held by Paradice Investment Management Llc

February 15, 2018 - By Hazel Jackson

Paradice Investment Management Llc increased its stake in Orthofix Intl N V (OFIX) by 10.01% based on its latest 2017Q3 regulatory filing with the SEC. Paradice Investment Management Llc bought 14,300 shares as the company’s stock rose 11.95% with the market. The institutional investor held 157,200 shares of the medical and dental instruments company at the end of 2017Q3, valued at $7.43M, up from 142,900 at the end of the previous reported quarter. Paradice Investment Management Llc who had been investing in Orthofix Intl N V for a number of months, seems to be bullish on the $960.73M market cap company. The stock increased 0.67% or $0.35 during the last trading session, reaching $52.75. About 9,170 shares traded. Orthofix International N.V. (NASDAQ:OFIX) has declined 3.00% since February 15, 2017 and is downtrending. It has underperformed by 19.70% the S&P500.

Hollow Brook Wealth Management Llc decreased its stake in Gilead Sciences Inc (GILD) by 50.42% based on its latest 2017Q3 regulatory filing with the SEC. Hollow Brook Wealth Management Llc sold 85,541 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 84,110 shares of the health care company at the end of 2017Q3, valued at $6.82M, down from 169,651 at the end of the previous reported quarter. Hollow Brook Wealth Management Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $107.01 billion market cap company. The stock increased 0.12% or $0.1 during the last trading session, reaching $81.92. About 2.21 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 15, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Since August 30, 2017, it had 0 insider purchases, and 13 insider sales for $51.09 million activity. The insider Alton Gregg H sold 30,000 shares worth $2.37 million. $3.68M worth of stock was sold by MARTIN JOHN C on Tuesday, January 2. $4.40 million worth of stock was sold by Washington Robin L on Thursday, September 7.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. North Point Portfolio Managers Corp Oh holds 2.77% or 202,405 shares. Moreover, Smithfield Company has 0.05% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Andra Ap stated it has 0.15% in Gilead Sciences, Inc. (NASDAQ:GILD). James Research Incorporated stated it has 32,880 shares. One Mngmt Limited holds 0.56% in Gilead Sciences, Inc. (NASDAQ:GILD) or 33,274 shares. Paradigm Advsrs Ltd Llc invested in 0.31% or 8,723 shares. Kepos Cap Lp reported 39,494 shares stake. 51,543 were accumulated by Mariner Wealth Limited Company. Evercore Wealth Ltd Limited Liability Company owns 53,861 shares. Morgens Waterfall Vintiadis & Inc reported 1.7% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 7,302 are owned by Bremer Trust Association. Huntington Natl Bank has 0.29% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Vertex One Asset Mgmt Incorporated accumulated 8,000 shares or 0.11% of the stock. Factory Mutual Insur Comm accumulated 588,900 shares or 0.52% of the stock. Marshall And Sullivan Wa reported 22,322 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Jefferies on Tuesday, September 6. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, May 30. Cowen & Co has “Buy” rating and $9000 target. The company was maintained on Wednesday, October 4 by Bank of America. Oppenheimer maintained the shares of GILD in report on Tuesday, October 20 with “Outperform” rating. The firm has “Buy” rating by Jefferies given on Wednesday, October 5. As per Friday, July 21, the company rating was maintained by BMO Capital Markets. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, February 7. The firm has “Hold” rating given on Wednesday, September 9 by Jefferies. Robert W. Baird maintained it with “Buy” rating and $87.0 target in Friday, September 15 report. The firm earned “Buy” rating on Wednesday, July 29 by Needham.

Among 5 analysts covering Orthofix International (NASDAQ:OFIX), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Orthofix International had 9 analyst reports since August 18, 2015 according to SRatingsIntel. The company was maintained on Sunday, September 10 by Jefferies. The rating was maintained by Jefferies on Thursday, June 29 with “Buy”. As per Tuesday, August 8, the company rating was maintained by BTIG Research. The firm has “Buy” rating given on Wednesday, August 9 by Gabelli. The stock of Orthofix International N.V. (NASDAQ:OFIX) has “Buy” rating given on Monday, October 30 by Jefferies.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>